DaVita
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 11.6b | 11.6b | 11.6b | 12.1b | 12.7b | 13.3b | 13.7b |
% growth | 1 % | 1 % | - | 5 % | 5 % | 4 % | 3 % |
EBITDA | 2.4b | 2.5b | 2.1b | 2.4b | 2.7b | 2.8b | 2.9b |
% EBITDA margin | 20 % | 21 % | 18 % | 19 % | 21 % | 21 % | 21 % |
Profit | 774m | 978m | 560m | 692m | 809m | 847m | 705m |
% profit margin | 7 % | 8 % | 5 % | 6 % | 6 % | 6 % | 5 % |
EV / revenue | 1.8x | 1.7x | 1.3x | 1.4x | 1.8x | 1.7x | 1.7x |
EV / EBITDA | 8.9x | 8.0x | 7.5x | 7.4x | 8.6x | 8.3x | 8.1x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Growth Equity VC | ||
N/A | N/A | IPO | |
* | N/A | $750m | Post IPO Debt |
Total Funding | - |
Recent News about DaVita
EditDaVita is a healthcare company specializing in providing comprehensive kidney care services. It primarily serves patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), focusing on delivering value-based care. Operating in the healthcare market, DaVita offers a range of services including dialysis treatment, kidney health education, and dietary guidance. The company generates revenue through its network of dialysis centers and integrated care programs, which are designed to improve patient outcomes and reduce healthcare costs. DaVita's business model revolves around patient-centric care, leveraging clinical metrics to track and enhance treatment efficacy. The company also provides educational resources such as Kidney Smart classes and risk quizzes to help patients manage their kidney health proactively. By focusing on holistic and equitable care, DaVita aims to transform the kidney care landscape and build a robust healthcare community.
Keywords: kidney care, dialysis, chronic kidney disease, end-stage renal disease, value-based care, patient-centric, healthcare, integrated care, dietary guidance, clinical metrics.